1. Home
  2. INBS vs ICCM Comparison

INBS vs ICCM Comparison

Compare INBS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.35

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$2.22

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBS
ICCM
Founded
2016
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
8.3M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
INBS
ICCM
Price
$2.35
$2.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
95.8K
94.1K
Earning Date
05-08-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,980,484.00
N/A
Revenue This Year
$778.48
$139.51
Revenue Next Year
N/A
$75.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.13
52 Week High
$24.90
$9.54

Technical Indicators

Market Signals
Indicator
INBS
ICCM
Relative Strength Index (RSI) 50.33 37.78
Support Level $2.26 $2.12
Resistance Level $2.45 $3.59
Average True Range (ATR) 0.35 0.23
MACD -0.04 -0.03
Stochastic Oscillator 24.50 13.53

Price Performance

Historical Comparison
INBS
ICCM

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: